Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 25 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Business News News

Business Business Latest News,Business Business Headlines

Here are some of the biggest movers of Monday.

Biogen Inc. shares BIIB rallied 5% following a full-day halt during the regular session as a Food and Drug Administration committee convened to vote on an approval recommendation for the biotech’s Alzheimer’s drug candidate it makes with Eisai Co. ESALF The committee voted unanimously... Biogen Inc.

Oracle Corp. ORCL stock rose 4%. It is slated to report fiscal fourth-quarter earnings after the bell on Monday. Analysts polled by FactSet expect the software giant to report adjusted earnings of $1.58 a share on sales of $13.7 billion. Teck Resources TECK TECK.B stock edged higher as Glencore GLEN lodged a bid for its coal unit, in addition to a $23 billion offer for the whole company.Carvana shares CVNA fell 1%, following a 21% downturn on Friday for the volatile used-car retailer.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in BUSİNESS

Business Business Latest News, Business Business Headlines